Showing results (181-190 of 222) with videos related to

Sort By:
Pageof 23
International Journal of Immunopharmacology|January 1, 1988
In vitro effect of TP-1 (a calf thymic extract) on suppressor T-cell function of patients with autoimmune chronic active hepatitisC J O'Brien, K T Nouri-Aria, J E Hegarty, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 14, 2014
Interference of confounding factors on the use of (1,3)-beta-D-glucan in the diagnosis of invasive candidiasis in the intensive care unitG Lo Cascio, R Koncan, G Stringari, et al.
Minerva Anestesiologica|December 4, 2001
[Prevalence of nosocomial infections in Intensive Care Units in Triveneto area, Italy]R Luzzati, L Antozzi, R Bellocco, et al.
Hepatology (Baltimore, Md.)|March 1, 1985
T lymphocyte sensitization to HBcAg and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver diseaseS Vento, J E Hegarty, A Alberti, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2013
Tenofovir plasma concentrations according to companion drugs: a cross-sectional study of HIV-positive patients with normal renal functionA Calcagno, D Gonzalez de Requena, M Simiele, et al.
Infection|July 7, 2014
Recommendations for the management of acute hepatitis B: position paper of the Italian Society for the Study of Infectious and Tropical Diseases (SIMIT)R Bruno, G Carosi, N Coppola, et al.
AIDS (London, England)|March 14, 2000
Cellular proviral HIV-DNA decline and viral isolation in naïve subjects with 500 x 10(6)/l CD4 cells treated with highly active antiretroviral therapyM Andreoni, S G Parisi, L Sarmati, et al.
The Journal of Antimicrobial Chemotherapy|February 2, 2008
The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferonD Aguilar Marucco, D Gonzalez de Requena, S Bonora, et al.
BMC Geriatrics|April 22, 2018
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 yearsG Guaraldi, A Malagoli, A Calcagno, et al.
Lancet (London, England)|February 15, 1986
Cell-mediated immunity and suppressor-T-cell defects to liver-derived antigens in families of patients with autoimmune chronic active hepatitisC J O'Brien, S Vento, P T Donaldson, et al.
Pageof 23